- Home
- MNY vs DXR Comparison
MNY vs DXR Comparison
Compare MNY & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNY
- DXR
- Stock Information
- Founded
- MNY 2014
- DXR 1970
- Country
- MNY Singapore
- DXR United States
- Employees
- MNY N/A
- DXR N/A
- Industry
- MNY
- DXR Medical/Dental Instruments
- Sector
- MNY
- DXR Health Care
- Exchange
- MNY Nasdaq
- DXR Nasdaq
- Market Cap
- MNY 47.1M
- DXR 42.6M
- IPO Year
- MNY N/A
- DXR N/A
- Fundamental
- Price
- MNY $1.07
- DXR $8.31
- Analyst Decision
- MNY
- DXR Strong Buy
- Analyst Count
- MNY 0
- DXR 1
- Target Price
- MNY N/A
- DXR $24.75
- AVG Volume (30 Days)
- MNY 144.2K
- DXR 38.6K
- Earning Date
- MNY 12-10-2024
- DXR 01-01-0001
- Dividend Yield
- MNY N/A
- DXR N/A
- EPS Growth
- MNY N/A
- DXR N/A
- EPS
- MNY N/A
- DXR 0.35
- Revenue
- MNY $90,185,081.00
- DXR $154,205.00
- Revenue This Year
- MNY $26.64
- DXR N/A
- Revenue Next Year
- MNY $25.46
- DXR N/A
- P/E Ratio
- MNY N/A
- DXR $24.10
- Revenue Growth
- MNY 24.60
- DXR N/A
- 52 Week Low
- MNY $0.85
- DXR $7.19
- 52 Week High
- MNY $3.46
- DXR $10.04
- Technical
- Relative Strength Index (RSI)
- MNY 40.01
- DXR 36.99
- Support Level
- MNY $1.02
- DXR $8.11
- Resistance Level
- MNY $1.13
- DXR $8.42
- Average True Range (ATR)
- MNY 0.07
- DXR 0.36
- MACD
- MNY -0.02
- DXR -0.13
- Stochastic Oscillator
- MNY 19.30
- DXR 0.53
About MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.